Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 2/20 | 0.37 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1816717 | 0.97 | TRIM24 (0.35) | TRIM24TRIM33ALDH1A1ESR2 | |
| SCHEMBL17531947 | 0.89 | TRIM24 (0.41) | TRIM24TRIM33ALDH1A1 | |
| SCHEMBL739206 | 0.85 | — | — | |
| SCHEMBL12621485 | 0.82 | — | — | |
| SCHEMBL7639721 | 0.81 | TRIM24 (0.37) | TRIM24TRIM33ALDH1A1ESR2 | |
| SCHEMBL11323249 | 0.80 | TP53 (0.38) | — | |
| SCHEMBL11227221 | 0.79 | — | — | |
| SCHEMBL14285867 | 0.77 | CYP1A2 (0.46) | — | |
| SCHEMBL742157 | 0.77 | GPR119 (0.33) | ALDH1A1 | |
| SCHEMBL4093712 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-8127578-A | — | — | None | — | — | JP | disclosed |
| US-9822237-B2 | Resin composition, film, polarizing plate protective film, polarizing plate, liquid crystal display device, and bis type alicyclic cardo phenol compound | FUJIFILM CORPORATION (JP) | 2017-11-21 | — | — | US | disclosed |
| US-20160090467-A1 | RESIN COMPOSITION, FILM, POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE, AND BIS TYPE ALICYCLIC CARDO PHENOL COMPOUND | FUJIFILM CORPORATION (JP) | 2016-03-31 | — | — | US | disclosed |
| EP-1238704-B1 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | DAICEL CHEM (JP) | 2015-01-21 | — | — | EP | disclosed |
| EP-1433527-B1 | CATALYSTS COMPRISED OF N-SUBSTITUTED CYCLIC IMIDES AND PROCESSES FOR PREPARING ORGANIC COMPOUNDS WITH THE CATALYSTS | DAICEL CHEM (JP) | 2013-11-06 | — | — | EP | disclosed |
| EP-1754693-B9 | Process for the production of esters or lactones | DAICEL CHEM (JP) | 2013-08-14 | — | — | EP | disclosed |
| EP-1754693-B1 | Process for the production of esters or lactones | DAICEL CHEM (JP) | 2013-02-06 | — | — | EP | disclosed |
| US-7759515-B2 | Catalyst comprising N-substituted cyclic imide compound and process for producing organic compounds using the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-07-20 | — | — | US | disclosed |
| US-7741514-B2 | Catalyst comprising N-substituted cyclic imide compound and process for producing organic compound using the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-06-22 | — | — | US | disclosed |
| US-20100029956-A1 | METHOD FOR PRODUCING ESTER OR LACTONE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20020128149-A1 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-09-12 | — | — | US | disclosed |
| EP-1238704-A2 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | Daicel Chemical Industries, Ltd. (JP) | 2002-09-11 | — | — | EP | disclosed |
| US-6313351-B1 | Process for producing alicyclic monoketones and process for producing alicyclic diketones | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2001-11-06 | — | — | US | disclosed |
| US-6229023-B1 | N-OXY OR HYDROXY CYCLIC IMIDE OXIDATION CATALYST | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2001-05-08 | — | — | US | disclosed |
| EP-1078922-A1 | PROCESS FOR THE PREPARATION OF ESTERS OR LACTONES | Daicel Chemical Industries, Ltd. (JP) | 2001-02-28 | — | — | EP | disclosed |
| EP-0990631-A1 | PROCESS FOR COOXIDIZING ORGANIC COMPOUNDS, PROCESS FOR PRODUCING EPOXY COMPOUNDS AND PROCESS FOR PRODUCING ESTERS OR LACTONES | Daicel Chemical Industries, Ltd. (JP) | 2000-04-05 | — | — | EP | disclosed |
| US-5654489-A | Process for producing alicyclic diketone compounds | NEW JAPAN CHEMICAL CO., LTD. (JP) | 1997-08-05 | — | — | US | disclosed |
| JP-H08127578-A | PRODUCTION OF LACTONES | NIPPON STEEL CHEM CO LTD | 1996-05-21 | — | — | JP | disclosed |
| EP-0697389-A1 | Process for producing alicyclic diketone compounds | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1996-02-21 | — | — | EP | disclosed |
| US-4555537-A | IMIDAZOLINE DERIVATIVES | AMERICAN CYANAMID COMPANY (US) | 1985-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160090467-A1 | RESIN COMPOSITION, FILM, POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE, AND BIS TYPE ALICYCLIC CARDO PHENOL COMPOUND | RRS1, XIAP, ARID2 | TRIM24 689/4885TRIM33 1914/4885ALDH1A1 3052/4885 |
| US-20100029956-A1 | METHOD FOR PRODUCING ESTER OR LACTONE | RIOX2, CBR1, AKR7A2 | TRIM24 2942/4885TRIM33 4518/4885ALDH1A1 90/4885 |
| US-20020128149-A1 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | NOX4, POR, NOX1 | TRIM24 771/4885TRIM33 2686/4885ALDH1A1 1339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.